4processed
Form 4 — Insider Transaction
Spyre Therapeutics, Inc.(SYRE)
Filing Date
June 25, 2026
Accepted
June 25, 2026
Accession No.
0001853327-26-000008
CIK
0001636282
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Burrows Scott L | Chief Financial Officer | Other | 15.0K | $14.5 | — | 113.0K | Common Stock | Jun 25, 2026 |
| Burrows Scott L | Chief Financial Officer | Other | 5.0K | $87.12 | — | 108.0K | Common Stock | Jun 25, 2026 |
| Burrows Scott L | Chief Financial Officer | Other | 10.0K | $87.14 | — | 98.0K | Common Stock | Jun 25, 2026 |
| Burrows Scott L | Chief Financial Officer | Other | 15.0K | $0 | — | 359.9K | Stock Option (Right to Buy) | Jun 25, 2026 |